Cargando…
Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
Angiogenesis is hallmark of clear cell renal cell carcinogenesis. Anti-angiogenic therapies have been successful in improving disease outcome; however, most patients treated with anti-angiogenic agents will eventually progress. In this study we report that clear cell renal cell carcinoma was associa...
Autores principales: | Serova, Maria, Tijeras-Raballand, Annemilaï, Santos, Celia Dos, Martinet, Matthieu, Neuzillet, Cindy, Lopez, Alfred, Mitchell, Dianne C., Bryan, Brad A., Gapihan, Guillaume, Janin, Anne, Bousquet, Guilhem, Riveiro, Maria Eugenia, Bieche, Ivan, Faivre, Sandrine, Raymond, Eric, de Gramont, Armand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122404/ https://www.ncbi.nlm.nih.gov/pubmed/27509260 http://dx.doi.org/10.18632/oncotarget.9542 |
Ejemplares similares
-
Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma
por: Santos, C D, et al.
Publicado: (2015) -
Targeting cancer cell metabolism in pancreatic adenocarcinoma
por: Cohen, Romain, et al.
Publicado: (2015) -
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
por: Serova, Maria, et al.
Publicado: (2015) -
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
por: Neuzillet, Cindy, et al.
Publicado: (2013) -
Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
por: Boilève, Alice, et al.
Publicado: (2021)